Cargando…

Serum ω-6/ω-3 polyunsaturated fatty acids ratio and diabetic retinopathy: A propensity score matching based case-control study in China

BACKGROUND: Optimal ω-6/ω-3 polyunsaturated fatty acids ratio (PUFAR) is reported to exert protective effects against chronic diseases. However, data on PUFAR and diabetic retinopathy (DR) remains scarce. We aimed to thoroughly quantify whether and how PUFAR was related to DR as well as its role in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Shuzhen, Jin, Dongzhen, Wang, Shengyao, Xu, Yanping, Li, Huihui, Chang, Yujie, Ma, Yange, Xu, Yixi, Guo, Chengnan, Peng, Fang, Huang, Ruogu, Lai, Mengyuan, Xia, Zhezheng, Che, Mingzhu, Zuo, Jingjing, Jiang, Depeng, Zheng, Chao, Mao, Guangyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478674/
https://www.ncbi.nlm.nih.gov/pubmed/34611616
http://dx.doi.org/10.1016/j.eclinm.2021.101089
_version_ 1784576114391252992
author Zhao, Shuzhen
Jin, Dongzhen
Wang, Shengyao
Xu, Yanping
Li, Huihui
Chang, Yujie
Ma, Yange
Xu, Yixi
Guo, Chengnan
Peng, Fang
Huang, Ruogu
Lai, Mengyuan
Xia, Zhezheng
Che, Mingzhu
Zuo, Jingjing
Jiang, Depeng
Zheng, Chao
Mao, Guangyun
author_facet Zhao, Shuzhen
Jin, Dongzhen
Wang, Shengyao
Xu, Yanping
Li, Huihui
Chang, Yujie
Ma, Yange
Xu, Yixi
Guo, Chengnan
Peng, Fang
Huang, Ruogu
Lai, Mengyuan
Xia, Zhezheng
Che, Mingzhu
Zuo, Jingjing
Jiang, Depeng
Zheng, Chao
Mao, Guangyun
author_sort Zhao, Shuzhen
collection PubMed
description BACKGROUND: Optimal ω-6/ω-3 polyunsaturated fatty acids ratio (PUFAR) is reported to exert protective effects against chronic diseases. However, data on PUFAR and diabetic retinopathy (DR) remains scarce. We aimed to thoroughly quantify whether and how PUFAR was related to DR as well as its role in DR detection. METHODS: This two-centre case-control study was conducted from August 2017 to June 2018 in China, participants were matched using a propensity score matching algorithm. We adopted multivariable logistic regression models and restricted cubic spline analyses to estimate the independent association of PUFAR with DR, adjusting for confounders identified using a directed acyclic graph. The value of PUFAR as a biomarker for DR identification was further evaluated by receiver operating characteristic analyses and Hosmer-Lemeshow tests. FINDINGS: An apparent negative relationship between PUFAR and DR was observed. Adjusted odds of DR decreased by 79% (OR: 0·21, 95% CI: 0·10–0·40) with an interquartile range increase in PUFAR. Similar results were also obtained in tertile analysis. As compared to those in the 1st tertile of PUFAR, the adjusted odds of DR decreased by 76% (OR: 0·24, 95% CI: 0·08–0·66) and 93% (OR: 0·07, 95% CI: 0·03–0·22) for subjects in the 2nd and 3rd tertiles, respectively. Good calibration and discrimination of the PUFAR associated predictive model were detected and PUFAR = 35 would be an ideal cut-off value for DR identification. INTERPRETATION: Our results suggest that serum PUAFR is inversely associated with DR. Although PUFAR-alteration is not observed amongst different stages of DR, it can serve as an ideal biomarker in distinguishing patients with DR from those without DR. FUNDING: This study was funded by Natural Science Foundation of Zhejiang Province, Zhejiang Basic Public Welfare Research Project, the Major Project of the Eye Hospital of Wenzhou Medical University, and the Academician's Science and Technology Innovation Program in Zhejiang province. Part of this work was also funded by the National Nature Science Foundation of China, and Research Project for College Students in Wenzhou Medical University.
format Online
Article
Text
id pubmed-8478674
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84786742021-10-04 Serum ω-6/ω-3 polyunsaturated fatty acids ratio and diabetic retinopathy: A propensity score matching based case-control study in China Zhao, Shuzhen Jin, Dongzhen Wang, Shengyao Xu, Yanping Li, Huihui Chang, Yujie Ma, Yange Xu, Yixi Guo, Chengnan Peng, Fang Huang, Ruogu Lai, Mengyuan Xia, Zhezheng Che, Mingzhu Zuo, Jingjing Jiang, Depeng Zheng, Chao Mao, Guangyun EClinicalMedicine Research Paper BACKGROUND: Optimal ω-6/ω-3 polyunsaturated fatty acids ratio (PUFAR) is reported to exert protective effects against chronic diseases. However, data on PUFAR and diabetic retinopathy (DR) remains scarce. We aimed to thoroughly quantify whether and how PUFAR was related to DR as well as its role in DR detection. METHODS: This two-centre case-control study was conducted from August 2017 to June 2018 in China, participants were matched using a propensity score matching algorithm. We adopted multivariable logistic regression models and restricted cubic spline analyses to estimate the independent association of PUFAR with DR, adjusting for confounders identified using a directed acyclic graph. The value of PUFAR as a biomarker for DR identification was further evaluated by receiver operating characteristic analyses and Hosmer-Lemeshow tests. FINDINGS: An apparent negative relationship between PUFAR and DR was observed. Adjusted odds of DR decreased by 79% (OR: 0·21, 95% CI: 0·10–0·40) with an interquartile range increase in PUFAR. Similar results were also obtained in tertile analysis. As compared to those in the 1st tertile of PUFAR, the adjusted odds of DR decreased by 76% (OR: 0·24, 95% CI: 0·08–0·66) and 93% (OR: 0·07, 95% CI: 0·03–0·22) for subjects in the 2nd and 3rd tertiles, respectively. Good calibration and discrimination of the PUFAR associated predictive model were detected and PUFAR = 35 would be an ideal cut-off value for DR identification. INTERPRETATION: Our results suggest that serum PUAFR is inversely associated with DR. Although PUFAR-alteration is not observed amongst different stages of DR, it can serve as an ideal biomarker in distinguishing patients with DR from those without DR. FUNDING: This study was funded by Natural Science Foundation of Zhejiang Province, Zhejiang Basic Public Welfare Research Project, the Major Project of the Eye Hospital of Wenzhou Medical University, and the Academician's Science and Technology Innovation Program in Zhejiang province. Part of this work was also funded by the National Nature Science Foundation of China, and Research Project for College Students in Wenzhou Medical University. Elsevier 2021-08-16 /pmc/articles/PMC8478674/ /pubmed/34611616 http://dx.doi.org/10.1016/j.eclinm.2021.101089 Text en © 2021 Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Paper
Zhao, Shuzhen
Jin, Dongzhen
Wang, Shengyao
Xu, Yanping
Li, Huihui
Chang, Yujie
Ma, Yange
Xu, Yixi
Guo, Chengnan
Peng, Fang
Huang, Ruogu
Lai, Mengyuan
Xia, Zhezheng
Che, Mingzhu
Zuo, Jingjing
Jiang, Depeng
Zheng, Chao
Mao, Guangyun
Serum ω-6/ω-3 polyunsaturated fatty acids ratio and diabetic retinopathy: A propensity score matching based case-control study in China
title Serum ω-6/ω-3 polyunsaturated fatty acids ratio and diabetic retinopathy: A propensity score matching based case-control study in China
title_full Serum ω-6/ω-3 polyunsaturated fatty acids ratio and diabetic retinopathy: A propensity score matching based case-control study in China
title_fullStr Serum ω-6/ω-3 polyunsaturated fatty acids ratio and diabetic retinopathy: A propensity score matching based case-control study in China
title_full_unstemmed Serum ω-6/ω-3 polyunsaturated fatty acids ratio and diabetic retinopathy: A propensity score matching based case-control study in China
title_short Serum ω-6/ω-3 polyunsaturated fatty acids ratio and diabetic retinopathy: A propensity score matching based case-control study in China
title_sort serum ω-6/ω-3 polyunsaturated fatty acids ratio and diabetic retinopathy: a propensity score matching based case-control study in china
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478674/
https://www.ncbi.nlm.nih.gov/pubmed/34611616
http://dx.doi.org/10.1016/j.eclinm.2021.101089
work_keys_str_mv AT zhaoshuzhen serumō6ō3polyunsaturatedfattyacidsratioanddiabeticretinopathyapropensityscorematchingbasedcasecontrolstudyinchina
AT jindongzhen serumō6ō3polyunsaturatedfattyacidsratioanddiabeticretinopathyapropensityscorematchingbasedcasecontrolstudyinchina
AT wangshengyao serumō6ō3polyunsaturatedfattyacidsratioanddiabeticretinopathyapropensityscorematchingbasedcasecontrolstudyinchina
AT xuyanping serumō6ō3polyunsaturatedfattyacidsratioanddiabeticretinopathyapropensityscorematchingbasedcasecontrolstudyinchina
AT lihuihui serumō6ō3polyunsaturatedfattyacidsratioanddiabeticretinopathyapropensityscorematchingbasedcasecontrolstudyinchina
AT changyujie serumō6ō3polyunsaturatedfattyacidsratioanddiabeticretinopathyapropensityscorematchingbasedcasecontrolstudyinchina
AT mayange serumō6ō3polyunsaturatedfattyacidsratioanddiabeticretinopathyapropensityscorematchingbasedcasecontrolstudyinchina
AT xuyixi serumō6ō3polyunsaturatedfattyacidsratioanddiabeticretinopathyapropensityscorematchingbasedcasecontrolstudyinchina
AT guochengnan serumō6ō3polyunsaturatedfattyacidsratioanddiabeticretinopathyapropensityscorematchingbasedcasecontrolstudyinchina
AT pengfang serumō6ō3polyunsaturatedfattyacidsratioanddiabeticretinopathyapropensityscorematchingbasedcasecontrolstudyinchina
AT huangruogu serumō6ō3polyunsaturatedfattyacidsratioanddiabeticretinopathyapropensityscorematchingbasedcasecontrolstudyinchina
AT laimengyuan serumō6ō3polyunsaturatedfattyacidsratioanddiabeticretinopathyapropensityscorematchingbasedcasecontrolstudyinchina
AT xiazhezheng serumō6ō3polyunsaturatedfattyacidsratioanddiabeticretinopathyapropensityscorematchingbasedcasecontrolstudyinchina
AT chemingzhu serumō6ō3polyunsaturatedfattyacidsratioanddiabeticretinopathyapropensityscorematchingbasedcasecontrolstudyinchina
AT zuojingjing serumō6ō3polyunsaturatedfattyacidsratioanddiabeticretinopathyapropensityscorematchingbasedcasecontrolstudyinchina
AT jiangdepeng serumō6ō3polyunsaturatedfattyacidsratioanddiabeticretinopathyapropensityscorematchingbasedcasecontrolstudyinchina
AT zhengchao serumō6ō3polyunsaturatedfattyacidsratioanddiabeticretinopathyapropensityscorematchingbasedcasecontrolstudyinchina
AT maoguangyun serumō6ō3polyunsaturatedfattyacidsratioanddiabeticretinopathyapropensityscorematchingbasedcasecontrolstudyinchina